Blog
RSS FeedPosted by Michael Wonder on 08 Mar 2021
World's most expensive drug given the green light in Scotland
8 March 2021 - A medicine known as the most expensive in the world has been approved to treat a rare ...
Posted by Michael Wonder on 08 Mar 2021
SMC - March 2021 decisions
8 March 2021 - Medicines which can be used to treat a rare genetic disease in children and some cancer ...
Posted by Michael Wonder on 09 Feb 2021
Scottish Medicines Consortium accepts Prostap SR DCS & Prostap 3 DCS (leuprorelin acetate) to treat early and advanced breast cancer
8 February 2021 - Takeda is pleased to announce that the Scottish Medicines Consortium has accepted Prostap SR DCS & ...
Posted by Michael Wonder on 09 Feb 2021
Scottish approval of a new treatment for people with chronic obstructive pulmonary disease - formoterol fumarate dihydrate/glycopyrronium bromide/budesonide
8 February 2021 - AstraZeneca today announced that Trixeo Aerosphere (formoterol fumarate/glycopyrronium bromide/budesonide) is now accepted for use by the SMC ...
Posted by Michael Wonder on 09 Feb 2021
SMC issues positive decision for treatment with AbbVie’s Rinvoq (upadacitinib) in severe active rheumatoid arthritis
9 February 2021 - Positive indication means upadacitinib will be available to those with previously treated severe active rheumatoid arthritis. ...
Posted by Michael Wonder on 09 Feb 2021
Scotland approves MS drug that was rejected in England and Wales
9 February 2021 - A drug that can reduce the number of relapses suffered by people with multiple sclerosis has been ...
Posted by Michael Wonder on 08 Feb 2021
SMC - February 2021 decisions
8 February 2021 - The SMC, which advises on newly licensed medicines for use by NHSScotland, has today published advice ...
Posted by Michael Wonder on 20 Jan 2021
Scottish Health Technologies Group: enhancing patient engagement
20 January 2021 - The Scottish Health Technologies Group provides evidence support and advice to the National Health Service in Scotland ...
Posted by Michael Wonder on 20 Jan 2021
Scotland backs Roche’s Rozlytrek for ROS1 lung cancer
19 January 2021 - The Scottish Medicines Consortium has given a green light to Roche’s Rozlytrek for a rare form ...
Posted by Michael Wonder on 18 Jan 2021
SMC - January 2021 decisions
18 January 2021 - The SMC, which advises on newly licensed medicines for use by NHSScotland, has today published advice ...
Posted by Michael Wonder on 11 Jan 2021
SMC to support innovative new medicines pathway
29 December 2020 - Experts from the Scottish Medicines Consortium are to support a new licensing and access pathway which ...
Posted by Michael Wonder on 07 Dec 2020
SMC - December 2020 decisions
7 December 2020 - Medicines which can be used to treat a form of blood cancer and a rare muscle ...
Posted by Michael Wonder on 12 Nov 2020
After NICE okay, Scots denied access to Vifor’s Veltassa
10 November 2020 - The SMC has ruled that there’s not enough evidence to support NHS funding of Vifor Pharma’s ...
Posted by Michael Wonder on 09 Nov 2020
New osteoporosis drug for women approved for use on NHS in Scotland
9 October 2020 - A new drug to treat women with severe cases of the bone disease osteoporosis has been ...
Posted by Michael Wonder on 09 Nov 2020
SMC - November 2020 decisions
9 November 2020 - Advice on eight new medicines for use in conditions including breast cancer, lung cancer and osteoporosis has ...